Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression

Prostaglandin E2, which is known to contribute to cancer progression, is inactivated by the catabolic enzyme, 15-hydroxyprostaglandin dehydrogenase (PGDH), which has tumor-suppressor activity in lung, colon, breast, and gastric cancers. Therefore, we evaluated the expression of PGDH in human bladder...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tseng-Rogenski, Stephanie, Gee, Jason, Ignatoski, Kathleen Woods, Kunju, Lakshmi P., Bucheit, Amanda, Kintner, Hallie J., Morris, David, Tallman, Christopher, Evron, Joshua, Wood, Christopher G., Grossman, H. Barton, Lee, Cheryl T., Liebert, Monica
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Investigative Pathology 2010
Materias:
Regular Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2832165/
https://ncbi.nlm.nih.gov/pubmed/20093479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2010.090875
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares